Antibodies against neo-epitope tTg complexed to gliadin are different and more reliable then anti-tTg for the diagnosis of pediatric celiac disease

Journal of Immunological Methods

Volumn 429, Issue , 2016, Pages 15-20

  Lerner, Aaron ^a,b   Jeremias, Patricia ^a   Neidhöfer, Sandra ^a   Matthias, Torsten ^a  

^a AESKUKIPP Institute   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antibodies; Autoantibodies; Celiac disease; Neo epitope tTg; Serological markers; Tissue transglutaminase

Indexed keywords

AUTOANTIBODY; GLIADIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEO EPITOPE PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; EPITOPE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ABDOMINAL PAIN; ADULT; ARTICLE; CELIAC DISEASE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; HUMAN; INTESTINE INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PEDIATRIC CELIAC DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; CHEMISTRY; IMMUNOLOGY;

ADULT; ANTIBODIES; CELIAC DISEASE; CHILD; EPITOPES; FEMALE; GLIADIN; HUMANS; MALE; MIDDLE AGED; TRANSGLUTAMINASES;

EID: 84957442644     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2015.12.006     Document Type: Article

References (22)

1. Barak M., Rozenberg O., Froom P., et al. Challenging our serological algorithm for celiac disease (CD) diagnosis by the ESPGHAN guidelines. Clin. Chem. Lab. Med. 2013, 51:e257-e259.
2. Bizzaro N., Tozzoli R., Villalta D., Fabris M., Tonutti E. Cutting-edge issues in celiac disease and in gluten intolerance. Clin. Rev. Allergy Immunol. 2012, 42:279-287.
3. Di Pisa M., Pascarella S., Scrima M., et al. Synthetic peptides reproducing tissue transglutaminase-Gliadin complex neo-epitopes as probes for antibody detection in celiac disease patients' sera. J. Med. Chem. 2015, 58:1390-1399.
4. Giersiepen K., Lelgemann M., Stuhldreher N., et al. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J. Pediatr. Gastroenterol. Nutr. 2012, 54:229-241.
5. Gujral N., Freeman H.J., Thomson A.B. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J. Gastroenterol. 2012, 18:6036-6059.
6. Husby S., Koletzko S., Korponay-Szabó I.R., et al. European Society for Pediatric Gastroenterology Hepatology and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 2012, 54:136-160.
7. Katz K.D., Rashtak S., Lahr B., et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am. J. Gastroentrol. 2011, 106:1333-1339.
8. Lerner A. Serological diagnosis of celiac disease - moving beyond the tip of the iceberg. Int. J. Celiac Dis. 2014, 2:64-66. Editorial.
9. Lerner A., Jeremias P., Matthias T. Outside of normal limits: false ± anti TG2 autoantibodies. Int. J. Celiac Dis. 2015, 3:87-90.
10. Lerner A., Neidhöfer S., Matthias T. Serological markers and/or intestinal biopsies in the case-finding of celiac disease. Int. J. Celiac dis 2015, 3:53-55.
11. Lerner A., Agmon-Levin N., Shapira Y., et al. The thrombophilic network of autoantibodies in celiac disease. BMC. Med. 2013, 11:89-95.
12. Lewis N.R., Scott B.B. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment. Pharmacol. Ther. 2010, 31:73-81.
13. Lytton S.D., Antiga E., Pfeiffer S., et al. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease-dermatitis herpetiformis. Clin. Chim. Acta 2013, 415:346-349.
14. Matthias T., Pfeiffer S., Selmi C., Eric Gershwin M. Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. Clin. Rev. Allergy Immunol. 2010, 38:298-301.
15. Matthias T., Neidhöfer S., Pfeiffer S., Prager K., Reuter S., Gershwin M.E. Novel trends in celiac disease. Cell. Mol. Immunol. 2011, 8:121-125.
16. Picarelli A., Di Tola M., Borghini R., et al. The high medical cost of celiac disease missed diagnosis: is it cheaper to suspect it in time?. Inter. Med. 2014, 4:3.
17. Porcelli B., Ferretti F., Vindigni C., Terzuoli L. Assessment of a test for the screening and diagnosis of celiac disease. J. Clin. Lab. Anal. 2014, (Nov 10, Epub ahead of print). 10.1002/jcla.21816.
18. Remes-Troche J.M., Ramírez-Iglesias M.T., Rubio-Tapia A., Alonso-Ramos A., Velazquez A., Uscanga L.F. Celiac disease could be a frequent disease in Mexico: prevalence of tissue transglutaminase antibody in healthy blood donors. J. Clin. Gastroenterol. 2006, 40:697-700.
19. Remes-Troche J.M., Rios-Vaca A., Ramírez-Iglesias M.T., et al. High prevalence of celiac disease in Mexican Mestizo adults with type 1 diabetes mellitus. J. Clin. Gastroenterol. 2008, 42:460-465.
20. Rozenberg O., Lerner A., Pacht A., et al. A new algorithm for the diagnosis of celiac disease. Cell. Mol. Immunol. 2011, 8:146-149.
21. Rozenberg O., Lerner A., Pacht A., et al. A novel algorithm for the diagnosis of celiac disease and a comprehensive review of celiac disease diagnostics. Crit. Rev. allerg. Immunol. 2012, 42:331-341.
22. Tozzoli R., Kodermaz G., Tampoia M., Visentini D., Tonutti E., Bizzaro N. [Detection of autoantibodies specific for transglutaminase-gliadin peptides complex: a new way to explore the celiac iceberg.] It. J. Lab. Med. 2010, 6:28-35.